The inhibitory effect of honokiol, a natural plant product, on vestibular schwannoma cells

Laryngoscope

Volumn 122, Issue 1, 2012, Pages 162-166

  Lee, Jong Dae ^a   Lee, Jae Yong ^a   Baek, Byoung Joon ^a   Lee, Byung Don ^a   Koh, Yoon Woo ^b   Lee, Won Sang ^b   Lee, Yu Jin ^c   Kwon, Byoung Mog ^c  

^a Soonchunhyang University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

apoptosis; ERK; Honokiol; vestibular schwannoma

Indexed keywords

HONOKIOL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONCENTRATION RESPONSE; DRUG EFFECT; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; NEURILEMOMA; NICK END LABELING; PRIORITY JOURNAL; VESTIBULAR DISORDER; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIPHENYL COMPOUNDS; CELL PROLIFERATION; HUMANS; LIGNANS; NEUROMA, ACOUSTIC; TUMOR CELLS, CULTURED;

EID: 84355162073     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.21781     Document Type: Article

References (20)

1. Welling DB, Packer MD, Chang LS,. Molecular studies of vestibular schwannomas: a review. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 341-346. (Pubitemid 47373981)
2. Neff BA, Welling DB, Akhmametyeva E, et al. The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level. Otol Neurotol 2006; 27: 197-208.
3. Clark JJ, Provenzano M, Diggelmann HR, et al. The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. Otol Neurotol 2008; 29: 846-853.
4. Mukherjee J, Kamnasaran D, Balasubramaniam A, et al. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate). Cancer Res 2009; 69: 5099-5107.
5. Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009; 361: 358-367.
6. Hahm ER, Arlotti JA, Marynowski SW, et al. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 2008; 14: 1248-1257. (Pubitemid 351302574)
7. Lee SJ, Cho YH, Park K, et al. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Biochem Pharmacol 2008; 75: 2289-2300.
8. Lee SK, Kim HN, Kang YR, et al. Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorg Med Chem 2008; 16: 8397-8402.
9. Neff BA, Welling DB,. Current concepts in the evaluation and treatment of neurofibromatosis type II. Otolaryngol Clin North Am 2005; 38: 671-684. (Pubitemid 40991311)
10. Aggarwal BB, Shishodia S,. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006; 71: 1397-1421.
11. Perabo FG, Von Löw EC, Ellinger J, et al. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 2008; 11: 6-12. (Pubitemid 351250324)
12. Bai X, Cerimele F, Ushio-Fukai M, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 2003; 278: 35501-35507. (Pubitemid 37102321)
13. Ishitsuka K, Hideshima T, Hamasaki M, et al. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 2005; 106: 1794-1800. (Pubitemid 41208596)
14. Battle TE, Arbiser J, Frank DA,. The natural product honokiol induces caspase dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 2005; 106: 690-697. (Pubitemid 40981267)
15. Li Z, Liu Y, Zhao X, et al. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur J Obstet Gynecol Reprod Biol 2008; 140: 95-102.
16. Morrison H, Sperka T, Manent J, et al. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 2007; 67: 520-527. (Pubitemid 46192188)
17. Ammoun S, Flaiz C, Ristic N, et al. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma. Cancer Res 2008; 68: 5236-5245.
18. Ammoun S, Ristic N, Matthies C, et al. Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244. Neurobiol Dis 2010; 37: 141-146.
19. Jacob A, Lee TX, Neff BA, et al. Phosphatidylinositol 3-kinase/AKT pathway activation in human vestibular schwannoma. Otol Neurotol 2008; 29: 58-68.
20. Lee TX, Packer MD, Huang J, et al. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells. Eur J Cancer 2009; 45: 1709-1720.